New Board member for Misonix
pharmafile | May 13, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing |Â Â MisonixÂ
Surgical device company Misonix has announced that Stavros Vizirgianakis has been appointed to its Board of directors.
The addition of Vizirgianakis expands the Misonix Board to seven members, with five members considered to be independent directors. Vizirgianakis is a Misonix shareholder, having acquired 5.3% of the company’s outstanding common stock in the open market in recent years.
Vizirgianakis has extensive medical device sales and marketing experience as a principal in Applied BioSurgical, a large medical device distributor in South Africa, and as a partner in MD Solutions Australasia PTY LTD, an Australian-based distributor of medical device products.
Michael McManus, president and chief executive officer of Misonix, said: “We are very pleased to welcome Stavros Vizirgianakis to our Board of directors. Stavros has a documented track record of success in marketing medical devices throughout the world. I have gotten to know Stavros over the years as he has successfully sold our products internationally. His industry knowledge, marketing experience, and his vast business relationships will be a great benefit to Misonix in the coming years.”






